Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
pegylated interferon alpha 2a, ribavirin
Locations
1
Taiwan
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Kaohsiung City, Taiwan
Start Date
June 1, 2007
Primary Completion Date
February 1, 2016
Completion Date
February 1, 2016
Last Updated
March 2, 2016
NCT00959166
NCT01289652
Lead Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions